|
|
|
|
|
|
|
|
132nd MAINE LEGISLATURE |
|
|
LD 1277 |
|
LR 2127(01) |
|
|
|
An Act Regarding
Controlled Substances Prescription Monitoring Activities |
|
Preliminary
Fiscal Impact Statement for Original Bill |
|
Sponsor: Rep. Moonen of Portland |
|
Committee: Health and Human Services |
|
Fiscal Note Required: Yes |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preliminary
Fiscal Impact Statement |
|
|
|
|
|
|
|
|
|
|
FY 2025-26 |
FY 2026-27 |
Projections FY 2027-28 |
Projections FY 2028-29 |
| Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$77,000 |
$62,000 |
$62,000 |
$62,000 |
|
|
|
|
|
|
|
| Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$77,000 |
$62,000 |
$62,000 |
$62,000 |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
The Department of
Health and Human Services will require General Fund appropriations of $77,000
in fiscal year 2025-26 and $62,000 in fiscal year 2026-27 for database
maintenance to implement the exception of testosterone from the Prescription
Monitoring Program. |
|
|
|
|
|
|
|